The focus of our research group is on the APOBEC cytidine deaminases and their role in inflammation and carcinogenesis.
Team
Research background and collaborations
Large-scale sequencing studies identified APOBEC cytidine deaminases as key drivers of mutagenesis and chromosomal aberrations in solid tumors, including pancreatic cancer. As important drivers of genomic and phenotypic plasticity, APOBEC enzymes may promote carcinogenesis, the ability of tumors to metastasize, and the development of drug resistance.
Our research group studies the role of APOBEC cytidine deaminases in tumor evolution, tumor heterogeneity, metastasis, and therapy resistance. We investigate how APOBEC-mediated mutagenesis, genomic aberrations, and post-translational modifications impact the pathogenesis and disease progression in cancer and inflammatory diseases. Our lab collaborates closely with research groups at the MD Anderson Cancer Center in Houston, Texas.
Publications
> Sonja Woermann's Bibliography - NCBI
MD/PhD thesis
Should you be interested in an experimental doctoral or master's thesis, we look forward to hearing from you via email: sonja.woermann@tum.de.
Grant support